Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -168.20%-200.74K | -533.84%-1.28M | 189.19%148K | 159.57%310.05K | 239.45%383.27K | 11.57%294.32K | -215.67%-201.6K | 75.73%-165.95K | 91.71%-520.45K | -132.08%-274.84K |
| Net income from continuing operations | -183.67%-1.48M | 3.20%-1.3M | 22.04%-1.22M | -5,171.07%-4.27M | -431.35%-3.13M | 5,353.04%1.77M | -138.47%-1.34M | -490.31%-1.56M | 101.19%84.19K | 128.17%945.75K |
| Operating gains losses | 110.43%2.11K | -160.88%-621 | 1.11%1.55K | 1,565.65%39.96K | 756.03%57.67K | -767.18%-20.27K | 4,023.08%1.02K | -81.22%1.54K | -98.92%2.4K | -105.25%-8.79K |
| Depreciation and amortization | 7.66%592.44K | -3.79%529.46K | -1.98%539K | 0.02%2.2M | -3.37%550.51K | -4.79%550.3K | 2.68%550.31K | 6.36%549.88K | 15.61%2.2M | 14.48%569.68K |
| Asset impairment expenditure | ---- | ---- | --0 | 2,467.63%3.36M | --3.36M | --0 | --0 | --0 | -105.39%-141.99K | --0 |
| Remuneration paid in stock | 36.03%27.22K | 86.25%107.86K | -70.42%17.13K | -47.72%152.96K | -70.42%17.13K | -90.66%20.01K | 466.32%57.91K | 466.32%57.91K | -52.33%292.59K | 277.55%57.91K |
| Deferred tax | --0 | 94.31%-17K | 148.57%17K | -78.95%-1.09M | -133.80%-505K | -25.13%-249K | -486.27%-299K | 75.35%-35K | 6.46%-608K | -340.23%-216K |
| Other non cashItems | 110.92%284.18K | 33.59%244.51K | -42.92%101.29K | -18.16%-2.91M | 60.95%-663.51K | -224.33%-2.6M | -46.44%183.04K | 159.18%177.46K | -376.30%-2.46M | -1,678.04%-1.7M |
| Change In working capital | -55.07%372.4K | -229.36%-840.52K | 7.21%687.19K | 2,473.71%2.82M | 824.61%698.27K | 64.50%828.93K | 1,402.57%649.74K | 224.91%640.99K | 102.28%109.49K | -78.26%75.52K |
| -Change in receivables | -299.16%-1.11M | -102.02%-22.32K | -52.04%501.1K | 1,515.80%2.56M | 37.41%687.8K | 54.10%-278.8K | 529.16%1.1M | 469.40%1.04M | 71.12%-180.72K | -77.75%500.55K |
| -Change in inventory | -61.31%394.4K | -24.20%269.48K | 60.16%-110.39K | -82.75%1.14M | -97.64%44.7K | 77.72%1.02M | -84.56%355.53K | -114.96%-277.11K | 160.22%6.62M | 719.02%1.9M |
| -Change in payables and accrued expense | 25,150.85%998.67K | -105.28%-987.38K | 239.95%320.09K | 86.31%-851.78K | 93.97%-146.01K | -99.07%3.96K | 70.83%-481K | 91.12%-228.72K | -191.35%-6.22M | -41.59%-2.42M |
| -Change in other current assets | 9.29%92.19K | 69.55%-100.31K | -123.16%-23.61K | 72.19%-31.4K | 9.92%111.79K | -24.37%84.35K | 6.66%-329.47K | 279.21%101.94K | -1,611.57%-112.9K | -11.62%101.7K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -168.20%-200.74K | -533.84%-1.28M | 189.19%148K | 159.57%310.05K | 239.45%383.27K | 11.57%294.32K | -215.67%-201.6K | 75.73%-165.95K | 91.71%-520.45K | -132.08%-274.84K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -1,102.29%-236.76K | -812.26%-977.71K | -2,204.14%-990.39K | 74.09%-314.01K | -146.45%-187.47K | 110.30%23.62K | 76.85%-107.17K | 90.31%-42.98K | 47.70%-1.21M | 94.37%-76.07K |
| Net PPE purchase and sale | -1,102.29%-236.76K | -812.26%-977.71K | -2,204.14%-990.39K | 74.09%-314.01K | -146.45%-187.47K | 110.30%23.62K | 76.85%-107.17K | 90.31%-42.98K | 47.70%-1.21M | 94.37%-76.07K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -1,102.29%-236.76K | -812.26%-977.71K | -2,204.14%-990.39K | 74.09%-314.01K | -146.45%-187.47K | 110.30%23.62K | 76.85%-107.17K | 90.31%-42.98K | 47.70%-1.21M | 94.37%-76.07K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 197.84%218.97K | 2,125.01%2.4M | 365.83%1.02M | -5.96%-913.74K | 40.57%-187K | 28.87%-223.81K | 5.48%-118.3K | -256.38%-384.63K | -107.87%-862.35K | -3.21%-314.63K |
| Net issuance payments of debt | 333.74%411.68K | 2,567.86%1.7M | 429.41%1.1M | -10.40%-718.42K | 47.27%-138.16K | 31.94%-176.13K | -3.18%-68.76K | -429.81%-335.37K | -344.07%-650.76K | -0.11%-262.04K |
| Net common stock issuance | --0 | --894K | ---- | ---- | ---- | --0 | --0 | ---- | --0 | ---- |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Interest paid (cash flow from financing activities) | -304.24%-192.72K | -228.25%-162.62K | -66.94%-82.24K | 7.69%-195.32K | 7.15%-48.84K | 14.65%-47.67K | 15.33%-49.54K | -10.39%-49.27K | -28.44%-211.59K | -22.04%-52.59K |
| Net other financing activities | ---- | ---32.64K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 197.84%218.97K | 2,125.01%2.4M | 365.83%1.02M | -5.96%-913.74K | 40.57%-187K | 28.87%-223.81K | 5.48%-118.3K | -256.38%-384.63K | -107.87%-862.35K | -3.21%-314.63K |
| Net cash flow | ||||||||||
| Beginning cash position | 2,495.41%440.1K | -32.44%300K | -88.44%119.9K | -71.43%1.04M | -93.48%111.1K | -99.15%16.96K | -81.48%444.04K | -71.43%1.04M | 184.88%3.63M | -61.57%1.7M |
| Current changes in cash | -332.14%-218.53K | 132.81%140.11K | 130.34%180.1K | 64.63%-917.7K | 101.32%8.8K | 133.60%94.14K | -3.20%-427.08K | 51.94%-593.56K | -210.07%-2.59M | 16.76%-665.55K |
| End cash Position | 99.45%221.57K | 2,495.41%440.1K | -32.44%300K | -88.44%119.9K | -88.44%119.9K | -93.48%111.1K | -99.15%16.96K | -81.48%444.04K | -71.43%1.04M | -71.43%1.04M |
| Free cash from | -287.81%-437.5K | -630.48%-2.26M | -245.34%-842.39K | 93.74%-137.83K | 151.85%181.93K | 576.61%232.94K | -6.96%-308.78K | 84.71%-243.93K | 74.70%-2.2M | 35.30%-350.91K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.